Bayesian Posterior Probabilities for Remdesivir Treatment Effects on COVID-19 Outcomes

Posterior probability estimates from a Bayesian analysis of remdesivir (RDV) treatment effects on COVID-19-related hospitalizations or all-cause death. The dataset, authored by Mazin Abdelghany, is a 9.5 KB Excel file last updated in April 2026.

Use Cases

• Validate Bayesian modeling approaches for clinical trial data based on the described posterior probability estimates.
• Compare treatment effect probabilities under different prior beliefs as suggested by the dataset's focus.
• Support meta-analyses of COVID-19 therapeutics using structured statistical output.
• Illustrate Bayesian inference results for educational purposes in biostatistics.

Strengths

• Dataset is openly licensed under CC-BY-4.0.
• File size is small (9.5 KB), facilitating quick download and inspection.
• Specific focus on Bayesian posterior probabilities for a defined clinical question.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Mazin Abdelghany via figshare.

Collection Method

Likely contains statistical outputs from a Bayesian analysis of clinical trial data.

Time Range

Temporal coverage is not specified.

Freshness

Last updated 2026-04-16 17:50:33; freshness should be verified.

Geography

Spatial coverage is not specified.